QI
MRNA icon

QS Investors’s Moderna MRNA Stock Holding History

QS Investors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1.27M Buy
5,410
+400
+8% +$71.5K 0.02% 431
2021
Q1 		$657K Sell
5,010
-600
-11% -$86.9K 0.01% 675
2020
Q4 		$586K Buy
+5,610
New +$568K 0.01% 709
2020
Q3 		– Sell
-2,800
Closed -$180K – 1403
2020
Q2 		$180K Sell
2,800
-1,400
-33% -$76.7K ﹤0.01% 1161
2020
Q1 		$126K Sell
4,200
-3,700
-47% -$85.1K ﹤0.01% 1197
2019
Q4 		$152K Sell
7,900
-5,800
-42% -$103K ﹤0.01% 1253
2019
Q3 		$219K Buy
+13,700
New +$202K ﹤0.01% 1183

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

QS Investors's MRNA Position: Q2 2021 in Review

QS Investors increased its Moderna (MRNA) stake by 8% in Q2 2021, buying an estimated $71.5K and bringing the position to 5,410 shares worth $1.27M. The position accounts for 0.02% of the portfolio, ranked #431.

QS Investors first reported a position in MRNA in Q3 2019 and has held it in 7 quarters since. 904 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

  • QS Investors held 5,410 shares of Moderna worth $1.27M as of Q2 2021.
  • QS Investors bought 400 Moderna shares in Q2 2021, an estimated $71.5K.
  • Moderna made up 0.02% of QS Investors's portfolio in Q2 2021, its #431 holding.
  • QS Investors first reported a position in Moderna in Q3 2019 and has held it in 7 quarters since.
  • 904 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.